BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28672809)

  • 1. Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.
    Tsai MJ; Chang WA; Tsai PH; Wu CY; Ho YW; Yen MC; Lin YS; Kuo PL; Hsu YL
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
    Piromkraipak P; Parakaw T; Phuagkhaopong S; Srihirun S; Chongthammakun S; Chaithirayanon K; Vivithanaporn P
    Can J Physiol Pharmacol; 2018 Aug; 96(8):798-806. PubMed ID: 29726704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
    El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
    Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
    Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
    Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
    Al-Amran FG; Hadi NR; Hashim AM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
    Shiota N; Shimoura K; Okunishi H
    Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
    Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
    Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
    Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
    Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
    Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
    Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
    Kim TH; Woo JS; Kim YK; Kim KH
    J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
    J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
    Shin IS; Jeon WY; Shin HK; Lee MY
    Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
    Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells.
    Suknuntha K; Yubolphan R; Krueaprasertkul K; Srihirun S; Sibmooh N; Vivithanaporn P
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):833-837. PubMed ID: 29582642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
    Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
    Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.